Literature DB >> 24684964

Comparison of methods to quantify posterior capsule opacification using forward and backward light scattering.

Nino Hirnschall1, Alja Crnej1, Vinod Gangwani1, Oliver Findl2.   

Abstract

PURPOSE: To compare forward and backward light scattering measurements to quantify posterior capsule opacification (PCO).
SETTING: Vienna Institute for Research in Ocular Surgery, Vienna, Austria.
DESIGN: Prospective single-center study.
METHODS: This observational study comprised consecutive patients scheduled for neodymium:YAG (Nd:YAG) capsulotomy for regeneratory PCO. The corrected distance visual acuity (CDVA) using Early Treatment of Diabetic Retinopathy Study charts and the contrast sensitivity under mesopic and photopic conditions using Pelli-Robson charts were assessed before an Nd:YAG capsulotomy was performed. Retroillumination images, rotating Scheimpflug scans (Pentacam HR), and straylight meter (C-Quant) and point-spread function (PSF) meter (Optical Quality Analysis System) measurements were performed before and after Nd:YAG capsulotomy.
RESULTS: The study enrolled 50 eyes of 50 patients. The mean uncorrected distance visual acuity and CDVA were 0.76 logMAR ± 0.18 (SD) and 0.68 ± 0.2 logMAR, respectively. The mean log contrast sensitivity (logCS) was 1.2 ± 0.15 logCS under photopic conditions and 1.05 ± 0.15 logCS under mesopic conditions. There was a moderate correlation between the Scheimpflug score and the Automated Quantification of After-Cataract score (r(2) = 0.37, P=.03). Furthermore, a moderate and close to significant correlation between the PSF meter and the straylight meter was observed (r(2) = 0.32; P=.07).
CONCLUSION: Each of the 4 devices assesses different aspects of a patient's quality of vision. Further developments should focus on methods that measure forward scatter of light in a large visual angle and are not too patient or examiner dependent.
Copyright © 2014 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24684964     DOI: 10.1016/j.jcrs.2013.10.035

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Repeatability, Reproducibility, and Comparability of Subjective and Objective Measurements of Intraocular Forward Scattering in Healthy Subjects.

Authors:  Ayaka Iijima; Kimiya Shimizu; Hidenaga Kobashi; Aya Saito; Kazutaka Kamiya
Journal:  Biomed Res Int       Date:  2015-06-14       Impact factor: 3.411

2.  Objective quantification and spatial mapping of cataract with a Shack-Hartmann wavefront sensor.

Authors:  Csaba Tamás Holló; Kata Miháltz; Máté Kurucz; Anita Csorba; Kinga Kránitz; Illés Kovács; Zoltán Zsolt Nagy; Gábor Erdei
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

3.  Posterior capsular opacification comparison between morphology and objective visual function.

Authors:  Chengzhe Lu; Shasha Yu; Hui Song; Yun Zhao; Shiyong Xie; Xin Tang; Xiaoyong Yuan
Journal:  BMC Ophthalmol       Date:  2019-02-04       Impact factor: 2.209

4.  Application of Spectral Domain Optical Coherence Tomography to Objectively Evaluate Posterior Capsular Opacity In Vivo.

Authors:  Shasha Yu; Chengzhe Lu; Xin Tang; Xiaoyong Yuan; Bo Yuan; Zhe Yu
Journal:  J Ophthalmol       Date:  2018-12-23       Impact factor: 1.909

5.  The Effect of Capsulotomy Shape on Intraocular Light-Scattering after Nd:YAG Laser Capsulotomy.

Authors:  Jun Li; Zhe Yu; Hui Song
Journal:  J Ophthalmol       Date:  2020-03-23       Impact factor: 1.909

6.  Objective Quantification of Image Quality and Optical Scatter Before and After Nd:YAG Capsulotomy Using a Double-Pass Technique.

Authors:  Abu-Bakar Zafar; Richard C Chu; Miranda N Bishara; Mujtaba A Qazi; Ashraf M Mahmoud; Jay S Pepose
Journal:  Clin Ophthalmol       Date:  2020-05-26

7.  Quantification of forward scattering based on the analysis of double-pass images in the frequency domain.

Authors:  Joan A Martínez-Roda; Carlos E García-Guerra; Fernando Diaz-Doutón; Jaume Pujol; Antoni Salvador; Meritxell Vilaseca
Journal:  Acta Ophthalmol       Date:  2019-05-03       Impact factor: 3.761

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.